Treace Medical Concepts Inc (TMCI)

$4.13 +0.15 (3.77%)
Market Cap 277.01M
Revenue (ttm) 212.69M
Net Income (ttm) -59.00M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -27.74%
Debt to Equity Ratio 0.72
Volume 211,516
Avg Vol 800,326
Day's Range N/A - N/A
Shares Out 64.87M
Stochastic %K 15%
Beta 1.39
Analysts Hold
Price Target $3.56

Company Profile

Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty System, enables surgeons to correct all three dimensions of the bunion deformity, stabilize the first TMT joint, and allow return to weight-bearing in a walking boot; minimally invasive products for four bunion classes; Nanoplasty 3D Minimally Invasive Bunion Correction System delivers a reproducible 3D correction of the bunion deform...

Industry: Medical Devices
Sector: Healthcare
Phone: 904 373 5940
Address:
100 Palmetto Park Place, Ponte Vedra, United States
NeonRaider
NeonRaider Jun. 23 at 6:06 PM
$TMCI
0 · Reply
Sidoti
Sidoti Jun. 23 at 11:23 AM
Treace Medical ($TMCI) Management Team presented last week at the Sidoti Small-Cap Virtual Conference. Watch the replay here: http://dlvr.it/TT9by5
0 · Reply
focafoca99
focafoca99 Jun. 18 at 11:17 AM
$TMCI executed its first HyperPlate XM case, expanding its foot‑ankle implant portfolio.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 12 at 3:30 PM
$TMCI CEO purchased 24,606 shares at $4.03 for a total of $99,196. Treace John T. now owns 12,672,568 shares. https://ceo-buys.com
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 11 at 10:55 PM
$TMCI CEO purchased 52,317 shares at $4.03 for a total of $210,968. Treace John T. now owns 12,700,279 shares. https://ceo-buys.com
0 · Reply
Sidoti
Sidoti Jun. 9 at 2:27 PM
See these #healthcare management teams present live and submit your questions during Q&A. $OBIO $SBC $TMCI http://dlvr.it/TSy72G All investors are welcome to join free of charge: http://dlvr.it/TSy72H
0 · Reply
Ivan1720
Ivan1720 Jun. 8 at 1:46 PM
$TMCI The CEO bought 30,000 shares at $3.56 not long ago
0 · Reply
FonsieTrader
FonsieTrader Jun. 6 at 9:46 AM
$TMCI The most bullish thing about this chart isn’t the rally. It’s the refusal to sell off. While fear hit the broader market, buyers continued defending the trend. 📈 Relative Strength 📈 Strong momentum 📈 Accumulation signals improving If markets stabilize next week, names showing this type of strength are often the first to lead. Watching closely.
0 · Reply
Dizzysquiggles
Dizzysquiggles Jun. 2 at 4:18 PM
$TMCI I don’t know what to think of the insider buy. But dayyuuummmm that’s a big kid purchase
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 1 at 10:40 PM
$TMCI CEO purchased 50,000 shares at $3.56 for a total of $177,915. Treace John T. now owns 12,647,962 shares. https://ceo-buys.com
0 · Reply
Latest News on TMCI
Treace Medical Concepts Transcript: Sidoti Small-Cap Virtual Investor Conference

Jun 18, 2026, 1:45 PM EDT - 12 days ago

Treace Medical Concepts Transcript: Sidoti Small-Cap Virtual Investor Conference

Treace Medical announces first surgical case with HyperPlate XM implant

2026-06-18T11:27:34.000Z - 13 days ago

Treace Medical announces first surgical case with HyperPlate XM implant

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

Jun 18, 2026, 7:05 AM EDT - 13 days ago

Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System

Treace to Present at the Sidoti Small Cap Conference

Jun 11, 2026, 4:05 PM EDT - 19 days ago

Treace to Present at the Sidoti Small Cap Conference

Treace Medical Concepts Transcript: AGM 2026

May 19, 2026, 11:00 AM EDT - 6 weeks ago

Treace Medical Concepts Transcript: AGM 2026

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

May 12, 2026, 8:05 AM EDT - 7 weeks ago

Treace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses

Treace Medical Concepts Earnings Call Transcript: Q1 2026

May 8, 2026, 8:00 AM EDT - 7 weeks ago

Treace Medical Concepts Earnings Call Transcript: Q1 2026

Treace Medical Concepts Earnings release: Q1 2026

May 8, 2026, 8:00 AM EDT - 7 weeks ago

Treace Medical Concepts Earnings release: Q1 2026

Treace Medical Concepts Quarterly report: Q1 2026

May 8, 2026, 8:00 AM EDT - 7 weeks ago

Treace Medical Concepts Quarterly report: Q1 2026

Treace Medical Concepts Reports First Quarter 2026 Financial Results

May 8, 2026, 7:05 AM EDT - 7 weeks ago

Treace Medical Concepts Reports First Quarter 2026 Financial Results

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Apr 24, 2026, 7:05 AM EDT - 2 months ago

Treace to Report First Quarter 2026 Financial Results on May 8, 2026

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

Apr 7, 2026, 9:04 AM EDT - 3 months ago

Treace Announces First Surgical Cases with the SuperBite™ Compression Screw System

Treace Medical Concepts Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Treace Medical Concepts Proxy statement: Proxy filing

Treace Medical Concepts Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Treace Medical Concepts Proxy statement: Proxy filing

Treace Medical price target lowered to $2 from $3 at Truist

2026-03-02T14:26:02.000Z - 4 months ago

Treace Medical price target lowered to $2 from $3 at Truist

Treace Medical price target lowered to $2.25 from $2.50 at UBS

2026-03-02T14:12:23.000Z - 4 months ago

Treace Medical price target lowered to $2.25 from $2.50 at UBS

Treace Medical price target lowered to $7 from $7.50 at Lake Street

2026-03-02T13:59:33.000Z - 4 months ago

Treace Medical price target lowered to $7 from $7.50 at Lake Street

Treace Medical Concepts Earnings Call Transcript: Q4 2025

Feb 27, 2026, 8:00 AM EST - 4 months ago

Treace Medical Concepts Earnings Call Transcript: Q4 2025

Treace Medical Concepts Annual report: Q4 2025

Feb 27, 2026, 8:00 AM EST - 4 months ago

Treace Medical Concepts Annual report: Q4 2025

Treace Medical Concepts Earnings release: Q4 2025

Feb 27, 2026, 8:00 AM EST - 4 months ago

Treace Medical Concepts Earnings release: Q4 2025

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

Feb 27, 2026, 7:05 AM EST - 4 months ago

Treace Medical Concepts Reports Fourth Quarter and Full-Year 2025 Financial Results

Treace Medical to highlight new product innovations, present data at ACFAS

2026-02-24T12:45:38.000Z - 4 months ago

Treace Medical to highlight new product innovations, present data at ACFAS

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference

Feb 24, 2026, 7:05 AM EST - 4 months ago

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2026 ACFAS Annual Scientific Conference

Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026

Feb 12, 2026, 5:13 PM EST - 4 months ago

Treace Updates Date of Fourth Quarter and Full-Year 2025 Financial Results Release to February 27, 2026

Treace Medical Concepts Transcript: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 10:30 AM EST - 6 months ago

Treace Medical Concepts Transcript: 44th Annual J.P. Morgan Healthcare Conference

Treace Medical Concepts Slides: 44th Annual J.P. Morgan Healthcare Conference

Jan 14, 2026, 10:30 AM EST - 6 months ago

Treace Medical Concepts Slides: 44th Annual J.P. Morgan Healthcare Conference

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

Jan 13, 2026, 7:05 AM EST - 6 months ago

Treace Announces Preliminary, Unaudited Fourth Quarter and Full-Year 2025 Revenue

Treace Medical reports completion of first Lapiplasty Lightning technology case

2026-01-08T21:45:15.000Z - 6 months ago

Treace Medical reports completion of first Lapiplasty Lightning technology case

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

Jan 8, 2026, 4:05 PM EST - 6 months ago

Treace Announces First Surgical Case Utilizing Lapiplasty® Lightning™ Technology

Treace Medical price target lowered to $3 from $5 at Stifel

2026-01-07T12:41:07.000Z - 6 months ago

Treace Medical price target lowered to $3 from $5 at Stifel

Treace Medical price target lowered to $3 from $4 at Truist

2025-12-18T14:21:47.000Z - 6 months ago

Treace Medical price target lowered to $3 from $4 at Truist

Treace Medical secures up to $175M in debt financing

2025-12-18T13:47:27.000Z - 6 months ago

Treace Medical secures up to $175M in debt financing

Treace Medical Secures Up to $175 Million in Debt Financing

Dec 18, 2025, 8:30 AM EST - 6 months ago

Treace Medical Secures Up to $175 Million in Debt Financing

Treace Medical Concepts Transcript: UBS Global Healthcare Conference 2025

Nov 10, 2025, 11:45 AM EST - 8 months ago

Treace Medical Concepts Transcript: UBS Global Healthcare Conference 2025

Treace Medical price target lowered to $4 from $7 at Truist

2025-11-10T15:10:47.000Z - 8 months ago

Treace Medical price target lowered to $4 from $7 at Truist

Treace Medical price target lowered to $5 from $6 at Stifel

2025-11-07T16:50:36.000Z - 8 months ago

Treace Medical price target lowered to $5 from $6 at Stifel

Treace Medical price target lowered to $7.50 from $12 at Lake Street

2025-11-07T14:06:07.000Z - 8 months ago

Treace Medical price target lowered to $7.50 from $12 at Lake Street

Treace Announces Participation in Two Upcoming Investor Conferences

Nov 7, 2025, 8:05 AM EST - 8 months ago

Treace Announces Participation in Two Upcoming Investor Conferences

Treace Medical price target lowered to $5.85 from $6.50 at UBS

2025-11-07T12:40:20.000Z - 8 months ago

Treace Medical price target lowered to $5.85 from $6.50 at UBS

Treace Medical Concepts Earnings Call Transcript: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Treace Medical Concepts Earnings Call Transcript: Q3 2025

Treace Medical Concepts Quarterly report: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Treace Medical Concepts Quarterly report: Q3 2025

Treace Medical Concepts Earnings release: Q3 2025

Nov 6, 2025, 4:30 PM EST - 8 months ago

Treace Medical Concepts Earnings release: Q3 2025

Treace to Report Third Quarter 2025 Financial Results on November 6, 2025

Oct 23, 2025, 4:05 PM EDT - 8 months ago

Treace to Report Third Quarter 2025 Financial Results on November 6, 2025

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting

Sep 10, 2025, 7:05 AM EDT - 10 months ago

Treace Highlights New Product Innovations and Updated Positive Clinical Study Data at the 2025 American Orthopaedic Foot & Ankle Society Annual Meeting

Treace Medical Concepts Transcript: Investor Day 2025

Sep 3, 2025, 9:00 AM EDT - 10 months ago

Treace Medical Concepts Transcript: Investor Day 2025

Treace Medical Concepts Slides: FY 2025

Sep 3, 2025, 9:00 AM EDT - 10 months ago

Treace Medical Concepts Slides: FY 2025

Treace Medical Concepts Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Treace Medical Concepts Earnings Call Transcript: Q2 2025

Treace Medical Concepts Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Treace Medical Concepts Quarterly report: Q2 2025

Treace Medical Concepts Earnings release: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 11 months ago

Treace Medical Concepts Earnings release: Q2 2025

Treace Medical Concepts Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 11 months ago

Treace Medical Concepts Reports Second Quarter 2025 Financial Results

Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025

Aug 7, 2025, 4:01 PM EDT - 11 months ago

Treace Medical to Host Investor Day Highlighting New Products on September 3, 2025

Notice to Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Napco Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Yo

Jul 1, 2025, 11:07 AM EDT - 1 year ago

Notice to Long-Term Shareholders of Maison Solutions Inc. (NASDAQ: MSS); Napco Security Technologies, Inc. (NASDAQ: NSSC); Treace Medical Concepts, Inc. (NASDAQ: TMCI); and Virtu Financial Inc. (NYSE: VIRT): Grabar Law Office is Investigating Claims on Yo

MSS NSSC VIRT

Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology

Jun 5, 2025, 1:00 PM EDT - 1 year ago

Treace Files Patent Infringement Suit Against Zimmer Biomet to Protect Lapiplasty® Bunion Technology

Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

May 9, 2025, 11:55 AM EDT - 1 year ago

Scott+Scott Attorneys at Law LLP Reminds Investors of the Ongoing Action Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

Treace Medical Concepts Earnings Call Transcript: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Treace Medical Concepts Earnings Call Transcript: Q1 2025

Treace Medical Concepts Quarterly report: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Treace Medical Concepts Quarterly report: Q1 2025

Treace Medical Concepts Earnings release: Q1 2025

May 8, 2025, 4:30 PM EDT - 1 year ago

Treace Medical Concepts Earnings release: Q1 2025

Scott+Scott Attorneys at Law LLP Alerts Investors an Action Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

May 6, 2025, 11:54 AM EDT - 1 year ago

Scott+Scott Attorneys at Law LLP Alerts Investors an Action Has Been Filed Against Treace Medical Concepts, Inc. (NASDAQ: TMCI)

NeonRaider
NeonRaider Jun. 23 at 6:06 PM
$TMCI
0 · Reply
Sidoti
Sidoti Jun. 23 at 11:23 AM
Treace Medical ($TMCI) Management Team presented last week at the Sidoti Small-Cap Virtual Conference. Watch the replay here: http://dlvr.it/TT9by5
0 · Reply
focafoca99
focafoca99 Jun. 18 at 11:17 AM
$TMCI executed its first HyperPlate XM case, expanding its foot‑ankle implant portfolio.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 12 at 3:30 PM
$TMCI CEO purchased 24,606 shares at $4.03 for a total of $99,196. Treace John T. now owns 12,672,568 shares. https://ceo-buys.com
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 11 at 10:55 PM
$TMCI CEO purchased 52,317 shares at $4.03 for a total of $210,968. Treace John T. now owns 12,700,279 shares. https://ceo-buys.com
0 · Reply
Sidoti
Sidoti Jun. 9 at 2:27 PM
See these #healthcare management teams present live and submit your questions during Q&A. $OBIO $SBC $TMCI http://dlvr.it/TSy72G All investors are welcome to join free of charge: http://dlvr.it/TSy72H
0 · Reply
Ivan1720
Ivan1720 Jun. 8 at 1:46 PM
$TMCI The CEO bought 30,000 shares at $3.56 not long ago
0 · Reply
FonsieTrader
FonsieTrader Jun. 6 at 9:46 AM
$TMCI The most bullish thing about this chart isn’t the rally. It’s the refusal to sell off. While fear hit the broader market, buyers continued defending the trend. 📈 Relative Strength 📈 Strong momentum 📈 Accumulation signals improving If markets stabilize next week, names showing this type of strength are often the first to lead. Watching closely.
0 · Reply
Dizzysquiggles
Dizzysquiggles Jun. 2 at 4:18 PM
$TMCI I don’t know what to think of the insider buy. But dayyuuummmm that’s a big kid purchase
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Jun. 1 at 10:40 PM
$TMCI CEO purchased 50,000 shares at $3.56 for a total of $177,915. Treace John T. now owns 12,647,962 shares. https://ceo-buys.com
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 28 at 10:35 PM
$TMCI CEO purchased 115,520 shares at $2.95 for a total of $340,589. Treace John T. now owns 12,597,962 shares. https://ceo-buys.com
0 · Reply
d5stocks
d5stocks May. 28 at 8:52 PM
$TMCI CEO bought another 115k shares today. with 60K shares at $3.02 today
0 · Reply
focafoca99
focafoca99 May. 20 at 9:53 PM
$TMCI declared its shareholders approved three new directors, an advisory compensation vote, and ratified Grant Thornton as its auditor.
0 · Reply
Ivan1720
Ivan1720 May. 20 at 4:01 PM
$TMCI started buying today ….will buy on pullbacks
0 · Reply
d5stocks
d5stocks May. 15 at 2:25 AM
$TMCI Bank of america filed 13G today. bought 3,533,774 shared 5.5% worth of the company and CEO bought 43000 shares on 05/12 @ $2.17, 49013 on 13th @$2.46 and, 61,750 on 14th @ $2.61.. three consecutive days.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures May. 14 at 11:35 PM
$TMCI CEO purchased 153,763 shares at $2.44 for a total of $375,505. Treace John T. now owns 12,482,442 shares. https://ceo-buys.com
0 · Reply
ThetaThetaTheta
ThetaThetaTheta May. 14 at 7:56 PM
$PYPL $SPY $TMCI Lmao it might hit that
0 · Reply
FonsieTrader
FonsieTrader May. 13 at 11:18 PM
$TMCI doing its thing
0 · Reply
knobs101
knobs101 May. 13 at 9:06 PM
$TMCI I've been watching this one. It's just hard for me to get excited about bunions. What kind of market is there for this technology?
1 · Reply
IsabellaDC
IsabellaDC May. 13 at 3:59 PM
Something to buy scan: $AEVA $CDRE $NAUT $TMCI $VELO
0 · Reply
StockScanners
StockScanners May. 13 at 2:52 AM
$TMCI keep watch if this holds above 2.22
0 · Reply
topstockalerts
topstockalerts May. 12 at 8:05 PM
$TMCI I looked away and it was higher
0 · Reply